Fresenius Kabi
Linda Franicevic serves as the Managing Director for Eastern Europe at Fresenius Kabi, overseeing a cluster of 15 countries and holding full responsibility for their P&L. With extensive experience in managing operations across Northern, Central, Eastern Europe, and the Middle East, Linda has led strategic initiatives, M&A projects, and recruitment processes while supervising multiple departments. Previous roles include Director for Serbia and South Eastern Europe and Marketing Manager for the South East Europe region, where Linda focused on business development and compliance. Additionally, Linda has a background in marketing management from their tenure at Studio Moderna and EPH, complemented by a Master's degree in Organisation and Management and a University Specialist degree in Economics from the Faculty of Economics & Business Zagreb.
This person is not in any offices
Fresenius Kabi
15 followers
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.